management innovation partners facilities and expertise target validation screening drug delivery medicinal chemistry pharmacology toxicology biologics external platforms key achievements news & events publications funding partners cdrd community project portfolio project portfolio working with cdrd research partners project approval criteria and process project search and evaluation team affiliated research institutions support for canadian health sciences companies innovation partners assets for partnering trainees the cdrd drug development training program candidates current trainee profiles careers careers current opportunities the cdrd employment hub contact us cdrd and zucara therapeutics have completed a license deal that provides access to zucara to select lead drug candidate . phase i clinical trials expected 2018 . zucara is developing a first in class therapeutic focused on improving glucagon counterregulation by inhibiting somatostatin which is dysregulated in type 1 diabetes . read more cdrd has launched a new spin off company sepset biosciences inc. sepset is developing a novel rapid diagnostic test that will enable healthcare professionals to provide earlier & more targeted treatment of sepsis . read more congrats to microdermics who won the cdrd life sciences award valued at 10 000 at the 2016 bcic new ventures competition . in this photo mike volker grant campany jon jafari cdrd and the ms society of canada have issued a global call for research projects to discover and develop treatments for progressive ms. details here by looking at the commonalities in multiple rare diseases rather than just one specific disease we are moving toward treating the root cause of rare diseases rather than managing the symptoms . find out how cdrd expands global industry partnerships with addition of astrazeneca this private public partnership will continue to support canadian health research projects by advancing promising research from the university labs through independent testing and validation and towards clinical trials and commercialization . read more quark venture has made a significant seed investment in sitka biopharma a critical value creating event that will enable sitka to advance their lead compound for the treatment of bladder cancer into clinical trials . read more health sciences researchers entrepreneurs and companies alike have the opportunity to collaborate with cdrd and thereby access its full suite of expertise infrastructure and broad partnerships and networks . find out how cdrd supports canadian small medium enterprises smes cdrd by the numbers over 1 100 early stage technologies evaluated for commercial potential over 200 projects on 134 distinct technologies 56 technologies advanced toward commercialization and or commercialized 7 spin off companies launched 14 technologies out licensed what is cdrd headquartered in vancouver british columbia the centre for drug research and development cdrd is canada s national drug development and commercialization engine . we work in partnership with academia industry government and foundations to provide the specialized expertise and infrastructure to identify and de risk promising discoveries generated by health related research and transform them into commercially viable investment opportunities for the private sector and ultimately into innovative new therapies for patients . in doing so cdrd is actively growing our national health sciences industry into a wholly optimized generator of economic prosperity for the country . since 2008 canada s networks of centres of excellence program has recognized cdrd as a centre of excellence for commercialization and research cecr . latest from the blog microdermics wins bcic new ventures competition & 10 000 in commercial support from cdrd zebrafish core facility at dalhousie cdrd atlantic node receives federal investment to build national centre of orphan drug research visit the blog news & events news events october 14 2016 zucara therapeutics & cdrd complete licensing deal to select lead therapeutic drug candidate september 29 2016 cdrd seeks new president & ceo september 13 2016 cdrd launches new company developing life saving sepsis diagnostic september 12 2016 global call to ms researchers for new projects with cdrd & ms society of canada september 9 2016 zucara therapeutics appoints michael midmer as ceo view all news 2016 10 25 7th annual don rix distinguished keynote featuring richard resnick 2016 10 24 2016 gairdner foundation lecture 2016 06 10 persomics seminar 2016 05 26 celebratory partnership luncheon and open house 2016 05 08 arcc conference 2016 view all events latest from twitter tweets by c d r d follow us on twitter a shared vision industryacademiagovernment home about us project portfolio working with cdrd trainees careers contact us sign up to our newsletter receive cdrd s e newsletter the cdrd pipeline and other e communications for regular updates on all our news and activities . copyright 2016 cdrd . all rights reserved .